5 Things You Need to Know about the COVID-19 Vaccine for Adolescents 12 through 17

Adolescents 12 through 17 are eligible for COVID-19 vaccination. In a clinical trial of the Pfizer-BioNTech COVID-19 Vaccine the most commonly reported side effects following vaccination in people 12 through 15 were mild to moderate and consistent with those reported in participants 16 and older.
Source: FDA Consumer Health Information Updates - Category: Consumer Health News Authors: Source Type: news